Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Leaderboard Analytics
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Eagle Pharmaceuticals, Inc. v. Slayback Pharma LLC et al
Case Number:
1:21-cv-01256
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
October 26, 2022
Apotex, Slayback Beat Lymphoma Drug Patent Suit In Del.
A Delaware federal judge cleared pharmaceutical companies Apotex and Slayback of patent infringement claims lodged by the maker of cancer drug Belrapzo over their new drug applications, ruling that the disputed products don't meet the "ready to use" limitation in the patent.
-
September 22, 2022
IP Forecast: Tyga's 'Wavy Baby' Shoe Row Goes To 2nd Circ.
The Second Circuit will consider what constitutes an "expressive" work in trademark law when it hears a controversial designer's appeal of a ruling the Vans footwear brand obtained to temporarily block a shoe line endorsed by the rapper Tyga. Here's a look at that case — plus all the other major intellectual property matters on deck in the coming week.